Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.
2.
3.

Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial.

Lucas GM, Mullen BA, Galai N, Moore RD, Cook K, McCaul ME, Glass S, Oursler KK, Rand C.

PLoS One. 2013 Jul 16;8(7):e68286. doi: 10.1371/journal.pone.0068286. Print 2013.

4.

Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.

White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, Wohl DA, Kaplan AH.

AIDS Behav. 2015 Jan;19(1):128-36. doi: 10.1007/s10461-014-0850-8.

5.

Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.

Mullen BA, Cook K, Moore RD, Rand C, Galai N, McCaul ME, Glass S, Oursler KK, Lucas GM.

BMC Infect Dis. 2011 Feb 15;11:45. doi: 10.1186/1471-2334-11-45.

6.

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.

Maru DS, Bruce RD, Walton M, Springer SA, Altice FL.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):176-81. doi: 10.1097/QAI.0b013e3181938e7e.

7.

A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.

Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, Larsen R, Hader S, Anthony MN, Weidle PJ.

Clin Infect Dis. 2006 Jun 1;42(11):1619-27. Epub 2006 Apr 28.

PMID:
16652320
8.

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.

Smith-Rohrberg D, Mezger J, Walton M, Bruce RD, Altice FL.

J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S48-53.

PMID:
17133204
9.

Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.

Babudieri S, Dorrucci M, Boschini A, Carbonara S, Longo B, Monarca R, Ortu F, Congedo P, Soddu A, Maida IR, Caselli F, Madeddu G, Rezza G.

AIDS Patient Care STDS. 2011 Jun;25(6):359-64. doi: 10.1089/apc.2010.0229.

PMID:
21612546
10.

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.

Springer SA, Qiu J, Saber-Tehrani AS, Altice FL.

PLoS One. 2012;7(5):e38335. doi: 10.1371/journal.pone.0038335. Epub 2012 May 31.

11.
12.

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.

Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, Springer SA, Friedland GH.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S376-87.

PMID:
15156426
13.

Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.

Berg KM, Mouriz J, Li X, Duggan E, Goldberg U, Arnsten JH.

Contemp Clin Trials. 2009 Sep;30(5):481-9. doi: 10.1016/j.cct.2009.05.003. Epub 2009 Jun 6.

14.

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.

Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD.

Clin Infect Dis. 2006 Jun 1;42(11):1628-35. Epub 2006 Apr 28.

PMID:
16652321
15.

Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Berg KM, Litwin AH, Li X, Heo M, Arnsten JH.

Clin Infect Dis. 2011 Nov;53(9):936-43. doi: 10.1093/cid/cir537. Epub 2011 Sep 2.

16.

Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Berg KM, Litwin A, Li X, Heo M, Arnsten JH.

Drug Alcohol Depend. 2011 Jan 15;113(2-3):192-9. doi: 10.1016/j.drugalcdep.2010.07.025. Epub 2010 Sep 15.

17.

Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA.

JAMA Intern Med. 2014 May;174(5):721-9. doi: 10.1001/jamainternmed.2014.601.

18.
19.

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD.

AIDS Patient Care STDS. 2007 Aug;21(8):564-74.

PMID:
17711381
20.

Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Maru DS, Bruce RD, Walton M, Mezger JA, Springer SA, Shield D, Altice FL.

AIDS Behav. 2008 Mar;12(2):284-93. Epub 2007 Dec 18.

Supplemental Content

Support Center